Skip to content

Clinical trials

Observational Myeloproliferative Disorders trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Country / region: Italy Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20091
20172
20181
20191
20202
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
Fondazione IRCCS Policlinico San Matteo di Pavia2
Icahn School of Medicine at Mount Sinai2
AUSL Romagna Rimini1
European Organisation for Research and Treatment of Cancer - EORTC1
Federico II University1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Paolo Corradini1
University of Milano Bicocca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders13
Polycythemia Vera5
Primary Myelofibrosis5
Thrombocythemia, Essential5
Multiple Myeloma2
Blast Crisis1
Breast Carcinoma In Situ1
Breast Neoplasms1
Breast Neoplasms, Male1
Burkitt Lymphoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.